<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03470428</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00024716</org_study_id>
    <nct_id>NCT03470428</nct_id>
  </id_info>
  <brief_title>Clinical Characteristics and Associations of the &quot;Good Fontan&quot; Patient</brief_title>
  <official_title>Clinical Characteristics and Associations of the &quot;Good Fontan&quot; Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New England Congenital Cardiology Association (NECCA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dartmouth College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Connecticut Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Vermont Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Child Heart Associates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Congenital Heart</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Massachusetts, Worcester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine what are some of the clinical characteristics and associations
      of Fontan patients who are doing well, as well as how accurate cardiology providers are at
      predicting the likelihood of future adverse event in their Fontan patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center prospective study that involves collecting data from patients as well
      as their cardiology providers in order to determine whether there is correlation between
      patient-reported quality of life assessments and clinician-identified assessments of their
      patients. The study also involves collecting data from the medical records of participating
      patients and entering it into our study database.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2018</start_date>
  <completion_date type="Anticipated">March 2026</completion_date>
  <primary_completion_date type="Anticipated">March 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Surprise question</measure>
    <time_frame>1 year</time_frame>
    <description>The ability of the cardiologist's response to the &quot;surprise&quot; question to predict adverse cardiac events within 1 year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical characteristics and associations of the &quot;good Fontan&quot;</measure>
    <time_frame>1 year</time_frame>
    <description>Clinical characteristics and associations of this group (the &quot;good Fontan&quot;) are different compared to those that are in the &quot;at-risk&quot; category (all others that do not fit into the &quot;good Fontan&quot; category). Data measurements will include relevant clinical data available for each patient, including but not limited to data from cardiac surgeries, catheterizations, MRIs, echocardiograms, exercise stress tests, current medications, labs, and patient responses to questionnaires.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between patient and provider assessments</measure>
    <time_frame>1 year</time_frame>
    <description>There will be a positive correlation of the patient's own assessment of quality of life with the clinician-identified designation of a &quot;good Fontan.&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinician factors associated with adverse events conversation with patients</measure>
    <time_frame>1 year</time_frame>
    <description>Clinician factors (years of experience, primary subspecialty, gender, parenthood) are associated with beliefs in regard to appropriate timing to discuss potential long-term adverse events to Fontan patients.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Congenital Heart Disease</condition>
  <condition>Single-ventricle</condition>
  <arm_group>
    <arm_group_label>Pediatric Fontan Patients</arm_group_label>
    <description>Participants ages 10 to 18 who have had Lateral Tunnel or Extracardiac Fontan procedures.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult Fontan Patients</arm_group_label>
    <description>Participants ages 18 to 60 who have had Lateral Tunnel or Extracardiac Fontan procedures.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with congenital heart disease who have undergone the Fontan procedure.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Extracardiac or Lateral Funnel Fontan

        Exclusion Criteria:

          -  Currently being evaluated for or listed for cardiac transplant

          -  Underwent Fontan revision or conversion

          -  Currently pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rahul Rathod, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rahul Rathod, MD</last_name>
    <phone>617-355-4890</phone>
    <email>rahul.rathod@childrens.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Elder, MD</last_name>
    <phone>203-785-2022</phone>
    <email>robert.elder@yale.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rahul Rathod, MD</last_name>
      <phone>617-355-4890</phone>
      <email>rahul.rathod@childrens.harvard.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>d'Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, Penny DJ, Brizard CP. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation. 2007 Sep 11;116(11 Suppl):I157-64.</citation>
    <PMID>17846297</PMID>
  </reference>
  <reference>
    <citation>Diller GP, Giardini A, Dimopoulos K, Gargiulo G, Müller J, Derrick G, Giannakoulas G, Khambadkone S, Lammers AE, Picchio FM, Gatzoulis MA, Hager A. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J. 2010 Dec;31(24):3073-83. doi: 10.1093/eurheartj/ehq356. Epub 2010 Oct 7.</citation>
    <PMID>20929979</PMID>
  </reference>
  <reference>
    <citation>Blume ED, Balkin EM, Aiyagari R, Ziniel S, Beke DM, Thiagarajan R, Taylor L, Kulik T, Pituch K, Wolfe J. Parental perspectives on suffering and quality of life at end-of-life in children with advanced heart disease: an exploratory study*. Pediatr Crit Care Med. 2014 May;15(4):336-42. doi: 10.1097/PCC.0000000000000072.</citation>
    <PMID>24583501</PMID>
  </reference>
  <reference>
    <citation>Lakin JR, Robinson MG, Bernacki RE, Powers BW, Block SD, Cunningham R, Obermeyer Z. Estimating 1-Year Mortality for High-Risk Primary Care Patients Using the &quot;Surprise&quot; Question. JAMA Intern Med. 2016 Dec 1;176(12):1863-1865. doi: 10.1001/jamainternmed.2016.5928.</citation>
    <PMID>27695853</PMID>
  </reference>
  <reference>
    <citation>Hamano J, Morita T, Inoue S, Ikenaga M, Matsumoto Y, Sekine R, Yamaguchi T, Hirohashi T, Tajima T, Tatara R, Watanabe H, Otani H, Takigawa C, Matsuda Y, Nagaoka H, Mori M, Yamamoto N, Shimizu M, Sasara T, Kinoshita H. Surprise Questions for Survival Prediction in Patients With Advanced Cancer: A Multicenter Prospective Cohort Study. Oncologist. 2015 Jul;20(7):839-44. doi: 10.1634/theoncologist.2015-0015. Epub 2015 Jun 8.</citation>
    <PMID>26054631</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2018</study_first_submitted>
  <study_first_submitted_qc>March 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 20, 2018</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children’s Hospital</investigator_affiliation>
    <investigator_full_name>Rahul Rathod</investigator_full_name>
    <investigator_title>Cardiologist</investigator_title>
  </responsible_party>
  <keyword>Fontan</keyword>
  <keyword>Single Ventricle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

